Daptomycin in Sodium Chloride
- Product NDC
- 0338-0712
- 11-digit product format
- 003380712
- Labeler code
- 0338
- Product ID
- 0338-0712_7b6f75eb-02dd-4906-9ee1-4c658a5e36b3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Daptomycin in Sodium Chloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Baxter Healthcare Corporation
- Application
- NDA213645
- Marketing category
- NDA
- Marketing start
- 2022-01-25
- Substance
- DAPTOMYCIN
- Active strength
- 350 mg/50mL
- Pharmacologic classes
- Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N213645-001 | DAPZURA RT | DAPTOMYCIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2022-01-25 | |
| N213645-002 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | DAPTOMYCIN | 350MG/50ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | |
| N213645-003 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | DAPTOMYCIN | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | |
| N213645-004 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | DAPTOMYCIN | 700MG/100ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | |
| N213645-005 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | DAPTOMYCIN | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N213645-001 | DAPZURA RT | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2022-01-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N213645-002 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 350MG/50ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N213645-003 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N213645-004 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 700MG/100ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N213645-005 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213645-001 | DAPZURA RT | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2022-01-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213645-002 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 350MG/50ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213645-003 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213645-004 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 700MG/100ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213645-005 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N213645-001 | DAPZURA RT | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2022-01-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N213645-002 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 350MG/50ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N213645-003 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N213645-004 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 700MG/100ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N213645-005 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213645-001 | DAPZURA RT | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2022-01-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213645-002 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 350MG/50ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213645-003 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213645-004 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 700MG/100ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213645-005 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213645-001 | DAPZURA RT | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2022-01-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213645-002 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 350MG/50ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213645-003 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213645-004 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 700MG/100ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213645-005 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213645-001 | DAPZURA RT | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2022-01-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213645-002 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 350MG/50ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213645-003 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213645-004 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 700MG/100ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213645-005 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213645-001 | DAPZURA RT | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2022-01-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213645-002 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 350MG/50ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213645-003 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213645-004 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 700MG/100ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213645-005 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213645-001 | DAPZURA RT | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2022-01-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213645-002 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 350MG/50ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213645-003 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 500MG/50ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213645-004 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 700MG/100ML (7MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213645-005 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | 1GM/100ML (10MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-02-27 | 5bbf6a4d5a75… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | bb7c543d1eb4… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N213645-001 | 11173189 | 2041-03-11 | U-3294 | Drug product | 2022-01-28 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Daptomycin in Sodium Chloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DAPTOMYCIN | 350 mg/50mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| NWQ5N31VKK | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 45ca3ac7-6ee8-4e99-92a6-dc0b401e151a | Product name | 1 | 20250724 |
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| 223d8260-7a4e-4ebd-9635-845422d6a8ad | Product name | 9 | 20240909 |
| ca803a62-3799-476f-bbc6-024f77cb0320 | Product name | 4 | 20240207 |
| cad85d83-8fb9-49f8-a5a6-a399af412964 | Product name | 1 | 20230922 |
| 8e59a5ed-f224-4156-b534-1ae4d0b6dfd7 | Product name | 1 | 20230721 |
| ea2c89ab-e8f8-425f-9693-c923fa1e1703 | Product name | 1 | 20220929 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0338-0712-24 | Daptomycin in Sodium Chloride | 24 in 1 CARTON | INJECTION, SOLUTION | 24 | 10 | |
| 0338-0712-24 | Daptomycin in Sodium Chloride | 50 mL in 1 BAG | INJECTION, SOLUTION | 50 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0338-0712-24 | ML - Milliliter | 0338-0712 | 32bac834-1f8b-42ff-941e-47285031b991 | 1 | 2023-09-05 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daptomycin in Sodium Chloride | DAPTOMYCIN IN SODIUM CHLORIDE | Baxter Healthcare Corporation | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 2025-04-30 | Warnings, Adverse reactions | 213645 NDA213645 0338-0712 |
| DAPZURA RT | DAPTOMYCIN | Baxter Healthcare Corporation | cb1283e1-35b8-425c-b338-d9ac0c7161f8 | 2022-01-25 | Warnings, Adverse reactions | 213645 NDA213645 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2632127 | DAPTOmycin 1000 MG in 100 ML Injection | PSN | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632130 | DAPTOmycin 350 MG in 50 ML Injection | PSN | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632132 | DAPTOmycin 500 MG in 50 ML Injection | PSN | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632133 | DAPTOmycin 700 MG in 100 ML Injection | PSN | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632127 | 100 ML daptomycin 10 MG/ML Injection | SCD | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632133 | 100 ML daptomycin 7 MG/ML Injection | SCD | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632132 | 50 ML daptomycin 10 MG/ML Injection | SCD | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632130 | 50 ML daptomycin 7 MG/ML Injection | SCD | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632127 | daptomycin 1000 MG per 100 ML Injection | SY | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632130 | daptomycin 350 MG per 50 ML Injection | SY | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632132 | daptomycin 500 MG per 50 ML Injection | SY | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
| 2632133 | daptomycin 700 MG per 100 ML Injection | SY | 7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0338-0712-24 | 00338071224 | 24 BAG in 1 CARTON (0338-0712-24) / 50 mL in 1 BAG | 24 bag | 2023-02-27 | No | No | Current |